Traws Pharma, Inc. (TRAW) › Operating Cash FlowTraws Pharma, Inc. (TRAW) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$15.81M2017: -$23.82M2018: -$22.70M2019: -$20.83M2020: -$23.07M2021: -$19.49M2022: -$16.29M2023: -$17.93M2024: -$29.79M2025: -$18.18M-$18.18M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$18.18M+39.0%2024-$29.79M-66.1%2023-$17.93M-10.1%2022-$16.29M+16.4%2021-$19.49M+15.5%2020-$23.07M-10.8%2019-$20.83M+8.2%2018-$22.70M+4.7%2017-$23.82M-50.6%2016-$15.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share